What is it about?

Long COVID is a new disease that affects millions of people and can have many symptoms that need treatment. New clinics for Long COVID have been set up in the UK, and there is a need to devise treatment pathways in the best way, taking those symptoms into account. This Delphi study explores what works best and then extends this to other Long Term Conditions (LTCs) where pathways might need improvement.

Featured Image

Why is it important?

This is important as Long COVID places a large burden on individuals, their carers and society alike. But healthcare systems have to deliver with limited resources given the current pandemic and healthcare workers are stretched. Finding ways to optimize healthcare for Long COVID and other LTCs can improve both wellbeing of individuals and the situation of healthcare services for LC and LTCs. This makes this Delphi study timely.


What is unique about our Delphi study is that we conduct it with input from patients, carers, clinicians and researchers alike to address questions regarding the complex situation of people with LC and other LTCs in our society in the era of a pandemic. We expect to publish our findings soon and these will inform policy makers to improve healthcare systems for integrated care pathways.

Christina Van der Feltz-Cornelis
University of York

Read the Original

This page is a summary of: STIMULATE-ICP-Delphi (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways Delphi): Study protocol, PLoS ONE, November 2022, PLOS,
DOI: 10.1371/journal.pone.0277936.
You can read the full text:

Open access logo


The following have contributed to this page